Rezolute, Inc. (RZLT)
Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypoglycemia; and clinical trials of ersodetug for tumor hyperinsulinism. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Rezolute, Inc.
NASDAQ:RZLTHealthcare · Biotechnology
-4.13%$3.95
AH$3.92-0.76%vs close
Mkt Cap$382.05M
Float85.01M
O/S96.72M
Vol
$ Vol
RVOL
Inst Own89.4%
SI22.6%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$77.59M
Total Assets$112.85M
Free Cash Flow-$64.64M
Debt & Equity
Debt 1%
Equity 99%
Total Debt$934K
Total Equity$100.69M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
- 1:50Reverse splitOct 13, 202050 shares → 1
Balance Sheet Details
Assets$112.85M
Liabilities$12.16M
Accounts Receivable$500K
Accounts Payable$5.03M
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 | 2012-06-30 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $31K | $0 | $0 | $0 | $0 | $13K | $18K | $48K | $1.07M | $12.57M | $8.27M | $5.85M | $2.4M | $4.56M | $5K |
| Gross Profit | -$31K | $0 | $0 | $0 | $0 | -$13K | -$18K | -$48K | -$1.07M | -$12.57M | -$8.27M | -$5.85M | -$2.4M | -$4.56M | -$5K |
| Gross Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research and Development | $53.8M | $61.53M | $55.74M | $43.81M | $32.49M | $14.99M | $14.45M | $19.08M | $17.28M | $12.09M | $9.45M | $4.7M | $34K | $3K | $0 |
| Selling, General, and Administrative | $29.17M | $18.37M | $14.68M | $12.18M | $9.36M | $7.91M | $6.07M | $6.82M | $9.1M | $8.23M | $5.5M | $6M | $5.13M | $6.1M | $43K |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $136K | $37K | $5.33M | $3.51M | $11K | $295 | $0 |
| Total Operating Expenses | $82.97M | $79.89M | $70.42M | $55.99M | $41.84M | $22.88M | $20.5M | $25.9M | $26.38M | $20.32M | $14.95M | $10.7M | $5.18M | $6.11M | $43K |
| Operating Income (EBIT) | -$82.97M | -$79.89M | -$70.42M | -$55.99M | -$41.84M | -$22.89M | -$20.52M | -$25.94M | -$28.73M | -$20.32M | -$14.95M | -$10.7M | -$5.18M | -$6.11M | -$46K |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $1.81M | $375K | $0 | $4.96M | $689K | $2K | $5K | $7K | $4.23M | $569K | $0 |
| Interest Income | $4.88M | $5.48M | $4.87M | $4.21M | $80K | $63K | $188K | $61K | $1K | $0 | $965 | $5K | $12K | $106K | $0 |
| Other Income (Expense) | $5.38M | $5.48M | $1.96M | $4.2M | $783K | $1.99M | $188K | -$4.5M | -$1.13M | $47K | $16K | -$664K | -$4.55M | -$621K | -$2K |
| Income Before Tax (EBT) | -$77.59M | -$74.41M | -$68.46M | -$51.79M | -$41.06M | -$20.9M | -$20.33M | -$30.45M | -$29.86M | -$20.28M | -$14.94M | -$11.36M | -$9.73M | -$6.73M | -$48K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$29K | $0 | -$11K | -$20K | $0 | $0 | $0 | $4K |
| Net Income | -$77.59M | -$74.41M | -$68.46M | -$51.79M | -$41.06M | -$20.9M | -$20.33M | -$30.42M | -$29.86M | -$20.28M | -$14.94M | -$11.36M | -$9.73M | -$6.73M | -$49K |
| Net Income Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Supplementary Data | |||||||||||||||
| EPS | -0.75 | -0.98 | -1.33 | -1.01 | -2.26 | -2.72 | -3.54 | -17.11 | -26.83 | -24.55 | -30.14 | -27.12 | -51.84 | -54.21 | -0.64 |
| Diluted EPS | -0.75 | -0.98 | -1.33 | -1.01 | -2.32 | -2.72 | -3.54 | -17.11 | -26.83 | -24.55 | -30.14 | -27.12 | -51.84 | -54.21 | -0.64 |
| Weighted Average OS | 103.91M | 76.00M | 51.47M | 51.19M | 18.20M | 7.67M | 5.75M | 1.78M | 1.11M | 825,934 | 495,464 | 419,003 | 187,693 | 124,091 | 77,352 |
| EBITDA | -$82.97M | -$74.38M | -$68.42M | -$51.76M | -$39.24M | -$20.51M | -$20.32M | -$25.44M | -$28.11M | -$19.16M | -$14.18M | -$11.22M | -$5.49M | -$6.16M | $0 |
| EBITDA Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 | 2012-06-30 |
| Assets | |||||||||||||||
| Current Assets | |||||||||||||||
| Cash and Cash Equivalents | $10.62M | $94.11M | $70.4M | $16.04M | $150.41M | $41.05M | $9.96M | $11.57M | $1.65M | $4.49M | $4.06M | $5.28M | $5.93M | $527 | $26K |
| Short-Term Investments | $97.19M | $73.75M | $56.48M | $85.86M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $107.8M | $167.86M | $126.87M | $101.9M | $150.41M | $41.05M | $9.96M | $11.57M | $1.65M | $4.49M | $4.06M | $5.28M | $5.93M | $527 | $26K |
| Accounts Receivable | $500K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $351K | $864K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $67K | $290K | $223K | $0 |
| Other Current Assets | -$500K | $3.29M | $1.78M | $0 | $0 | $0 | $0 | $571K | $362K | $442K | $430K | $770K | $83K | $242K | $179K |
| Total Current Assets | $107.8M | $171.15M | $128.65M | $104.91M | $152.1M | $41.99M | $10.52M | $12.14M | $2.01M | $4.93M | $4.49M | $6.12M | $6.31M | $816K | $1.07M |
| Long-Term Assets | |||||||||||||||
| Property, Plant & Equipment Net | $0 | $1.42M | $1.98M | $2.19M | $168K | $425K | $416K | $44K | $368K | $5.33M | $5.98M | $4.52M | $338K | $276K | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $29K | $37K | $44K | $52K | $59K | $9K | $13K | $0 |
| Long-Term Investments | $0 | $0 | $263K | $16.47M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $5.05M | $2.92M | $1.84M | $148K | $148K | $191K | $31K | $35K | $90K | $331K | $375K | $563K | $750K | $0 | $0 |
| Total Long-Term Assets | $5.05M | $4.34M | $4.08M | $18.81M | $316K | $616K | $447K | $108K | $495K | $5.7M | $6.41M | $5.15M | $1.1M | $288K | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $112.85M | $175.49M | $132.74M | $123.72M | $152.42M | $42.61M | $10.96M | $12.25M | $2.5M | $10.63M | $10.9M | $11.26M | $7.4M | $1.1M | $1.07M |
| Liabilities | |||||||||||||||
| Current Liabilities | |||||||||||||||
| Accounts Payable | $5.03M | $5.81M | $4.9M | $3.27M | $1.13M | $1.03M | $893K | $563K | $1.71M | $926K | $1.5M | $1.41M | $460K | $188K | $109K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $10K | $3.44M | $10K | $83K | $154K | $60K | $3.73M | $2.14M |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.03M | $108K | $15K | $13K | $408K | $1.19M | $0 |
| Other Current Liabilities | $3.7M | $2.27M | $1.81M | $883K | $0 | $77K | $120K | $6.53M | $336K | $131K | $109K | $37K | $433K | $158K | $0 |
| Total Current Liabilities | $11.42M | $11.91M | $9.61M | $5.2M | $2.46M | $1.97M | $3.23M | $8.38M | $6.25M | $1.77M | $1.73M | $1.71M | $964K | $5.27M | $2.36M |
| Long-Term Liabilities | |||||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $13.97M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $400K | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $468K | $468K | $468K | $412K | $407K | $387K | $209K | $2.12M | $216K | $330K | $0 | $480K | $34K | $0 | $0 |
| Total Long-Term Liabilities | $744K | $1.45M | $2.13M | $2.35M | $487K | $14.54M | $374K | $2.12M | $216K | $330K | $400K | $504K | $34K | $3.92M | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$3.92M | $0 |
| Total Liabilities | $12.16M | $13.36M | $11.73M | $7.55M | $2.95M | $16.51M | $3.6M | $10.5M | $6.46M | $2.1M | $2.13M | $2.21M | $998K | $5.27M | $2.36M |
| Stockholders' Equity | |||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $96K | $87K | $53K | $37K | $34K | $8K | $6K | $4K | $62K | $49K | $35K | $24K | $18K | $40K | $35K |
| Retained Earnings | -$481.44M | -$403.86M | -$329.44M | -$260.99M | -$209.2M | -$168.14M | -$147.24M | -$126.9M | -$94.18M | -$64.32M | -$44.04M | -$29.11M | -$17.75M | -$8.02M | -$1.29M |
| Comprehensive Income & Other | -$119K | -$7K | -$79K | -$351K | $0 | $0 | $0 | $0 | -$518K | -$1.99M | -$879K | -$137K | -$8K | $0 | $0 |
| Other Stockholders' Equity | $582.03M | $565.9M | $450.39M | $377.12M | $358.63M | $194.23M | $154.59M | $128.65M | $90.16M | $72.8M | $52.78M | $38.14M | $24.14M | $3.81M | -$35K |
| Total Equity | $100.69M | $162.13M | $121M | $116.17M | $149.47M | $26.1M | $7.37M | $1.75M | -$3.96M | $8.53M | $8.77M | $9.05M | $6.41M | -$4.16M | -$1.29M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $112.85M | $175.49M | $132.74M | $123.72M | $152.42M | $42.61M | $10.96M | $12.25M | $2.5M | $10.63M | $10.9M | $11.26M | $7.4M | $1.1M | $1.07M |
| Supplementary Data | |||||||||||||||
| Total Debt | $934K | $1.61M | $2.23M | $2.48M | $188K | $14.42M | $410K | $10K | $3.43M | $10K | $83K | $177K | $60K | $3.73M | $2.14M |
| Net Debt | -$9.68M | -$92.49M | -$68.17M | -$13.56M | -$150.22M | -$26.63M | -$9.54M | -$11.56M | $1.79M | -$4.48M | -$3.98M | -$5.1M | -$5.87M | $3.73M | $2.11M |
Cash Flow Statement
| Period | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 | 2012-06-30 |
| Operating Activities | |||||||||||||||
| Net Income | -$77.59M | -$74.41M | -$68.46M | -$51.79M | -$41.06M | -$20.9M | -$20.33M | -$30.45M | -$29.86M | -$20.28M | -$14.94M | -$11.36M | -$9.73M | -$6.73M | -$49K |
| Depreciation & Amortization | $31K | $31K | $36K | $30K | $13K | $13K | $18K | $49K | $1.07M | $1.11M | $751K | $134K | $11K | $295 | $221 |
| Deferred Income Tax | $0 | $0 | $0 | -$1.36M | $0 | -$1.78M | $102K | -$17K | $2.93M | $0 | $0 | $756K | $4.58M | $0 | $0 |
| Stock-Based Compensation | $14.46M | $7.12M | $7.36M | $7.27M | $3.69M | $3.96M | $3.32M | $2.64M | $5.1M | $6.01M | $3.76M | $2.85M | $1.08M | $3.69M | $0 |
| Changes in Working Capital: | |||||||||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $306K | $237K | $646K | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $222K | -$67K | $223K | $0 |
| Accounts Payable | -$748K | $1.42M | $1.08M | $2.14M | -$11K | $142K | $330K | -$548K | $824K | $112K | $26K | -$132K | $272K | $80K | -$1K |
| Other Working Capital | $1.08M | -$1.37M | $2.02M | -$1.11M | -$631K | -$2.26M | -$7.82M | $8.9M | $208K | -$268K | -$146K | -$16K | $46K | $7K | $0 |
| Total Working Capital Change | $330K | $47K | $3.1M | $1.02M | -$642K | -$2.12M | -$7.49M | $8.36M | $1.03M | -$155K | -$119K | $380K | $488K | $956K | -$1K |
| Other Non-Cash Items | -$1.87M | -$1.86M | $595K | $352K | -$1.61M | $384K | $222K | $4.12M | $5.63M | $1K | $53K | $166K | $405K | $456K | $10K |
| Net Cash from Operating | -$64.64M | -$69.08M | -$57.37M | -$44.48M | -$39.62M | -$20.44M | -$24.17M | -$15.3M | -$14.11M | -$13.31M | -$10.49M | -$7.08M | -$3.17M | -$1.63M | -$40K |
| Investing Activities | |||||||||||||||
| Capital Expenditures | $0 | $0 | $0 | -$153K | $0 | $0 | $0 | -$47K | -$6K | -$408K | -$2.09M | -$3.16M | -$70K | -$12K | -$2K |
| Acquisitions | $0 | $0 | $0 | $101.46M | $0 | $0 | $0 | $278K | $1.55M | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$178.18M | -$128.14M | -$66.4M | -$107.31M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $157.08M | $113.6M | $115.1M | $6M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | -$101.46M | $0 | $0 | $0 | $278 | $1.74M | $213K | $638K | -$450K | -$760K | $197K | $0 |
| Net Cash from Investing | -$21.1M | -$14.54M | $48.7M | -$101.46M | $0 | $0 | $0 | $231K | $1.73M | -$195K | -$1.45M | -$3.61M | -$830K | $185K | -$2K |
| Financing Activities | |||||||||||||||
| Debt Repaid | - | - | - | - | $16.01M | -$15M | - | - | - | $23K | $94K | $68K | - | -$1.57M | - |
| Common Stock Issuance | $2.24M | $107.33M | $49.02M | $12.33M | $122.82M | $41M | $24.05M | $0 | $4.5M | $14.64M | $5.36M | $11.18M | $8.93M | $0 | $11K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $14.01M | -$759K | $31.39M | -$4.47M | -$1.5M | $0 | -$299K | -$683K | -$890K | -$1.07M | -$1.64M | -$158K | -$2.01M |
| Net Cash from Financing | $2.24M | $107.33M | $63.03M | $11.57M | $148.98M | $51.53M | $22.55M | $25M | $9.54M | $13.93M | $10.73M | $10.04M | $9.93M | $1.42M | $11K |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$83.49M | $23.71M | $54.36M | -$134.37M | $109.36M | $31.09M | -$1.62M | $9.93M | -$2.84M | $425K | -$1.22M | -$656K | $5.93M | -$25K | -$32K |
| Supplementary Data | |||||||||||||||
| Operating Cash Flow | -$64.64M | -$69.08M | -$57.37M | -$44.48M | -$39.62M | -$20.44M | -$24.17M | -$15.3M | -$14.11M | -$13.31M | -$10.49M | -$7.08M | -$3.17M | -$1.63M | -$40K |
| Capital Expenditure | $0 | $0 | $0 | -$153K | $0 | $0 | $0 | -$47K | -$6K | -$408K | -$2.09M | -$3.16M | -$70K | -$12K | -$2K |
| Free Cash Flow | -$64.64M | -$69.08M | -$57.37M | -$44.63M | -$39.62M | -$20.44M | -$24.17M | -$15.35M | -$14.12M | -$13.72M | -$12.58M | -$10.24M | -$3.24M | -$1.64M | -$42K |
| Cash at Beginning | $94.11M | $70.4M | $16.04M | $150.41M | $41.05M | $9.96M | $11.57M | $1.65M | $4.49M | $4.06M | $5.28M | $5.93M | $527 | $26K | $37K |
| Cash at End | $10.62M | $94.11M | $70.4M | $16.04M | $150.41M | $41.05M | $9.96M | $11.57M | $1.65M | $4.49M | $4.06M | $5.28M | $5.93M | $527 | $5K |